Efficient Induction of Antigen-Specific CD8<sup>+</sup> T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles.

Pharmaceutics · 2022 · PMC9321026 · PMID 35890284

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, the proportion of CD8 + T cells exhibiting more than two functions showed a trend towards being larger for conditions using modified mRNA.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.